Hartmann M
Universitätshautklinik, Heidelberg, Germany.
Hautarzt. 2006 Nov;57(11):969-74. doi: 10.1007/s00105-006-1240-6.
The introduction of highly active antiretroviral therapy (HAART) has resulted in tremendous improvements in morbidity and mortality in HIV-infected patients. However, the use of these drugs has coincided with an increasing number of reports of gastrointestinal, hepatic or metabolic side effects. Soon after beginning antiretroviral treatment drug rashes, hypersensitivity reactions, immune reconstitution syndrome or injection site reaction are frequently seen. Under HAART dyslipidemia, impaired glucose metabolism and elevated liver function are observed. In the later treatment phase, lipodystrophy, a combination of peripheral lipoatrophy and central fat accumulation, occurs.
高效抗逆转录病毒疗法(HAART)的引入使HIV感染患者的发病率和死亡率有了显著改善。然而,使用这些药物的同时,胃肠道、肝脏或代谢方面副作用的报告数量也在增加。开始抗逆转录病毒治疗后不久,药物疹、过敏反应、免疫重建综合征或注射部位反应很常见。在HAART治疗下,会观察到血脂异常、葡萄糖代谢受损和肝功能升高。在治疗后期,会出现脂肪代谢障碍,即外周脂肪萎缩和中央脂肪堆积的组合。